EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review

Veronika Elisabeth Mikl, Mohammad Azizzadeh, Marie-Kathrin Breyer, Kevin Ten Haaf, Valentin Ritschl, Judit Simon, Tanja Stamm

Public Health Reviews · 20.07.2026 · 47

DOI: 10.3389/phrs.2026.1609133 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Public Health Reviews, online erschienen am 20.07.2026. Verfasst von Veronika Elisabeth Mikl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program Public Health, Institute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Low-dose computed tomography lung cancer screening (LDCT-LCS) significantly reduces mortality, yet identifying high-risk individuals while reducing over-screening remains challenging. Risk-based eligibility models are promising to optimize participant selection. Within the European context, we assessed the types, outcomes, and impact of these risk-based eligibility models for LDCT-LCS.

Methods

We systematically reviewed prediction model studies (PROSPERO CRD42025648906) across EMBASE, MEDLINE, and Cochrane Central Register of Controlled Trials. We included original research on adults aged 18+ at risk for LC, excluding East-Asian populations. Study characteristics, model type, performance and outcomes were extracted for narrative synthesis.

Results

The review included 46 articles (2003–2025), identifying 39 risk-prediction models. Models were primarily statistical (72%); PLCOm2012 was most frequent. Age (100%), smoking duration (91%), and intensity (72%) were the most common variables. Risk models improved eligibility and demonstrated cost-effectiveness over traditional criteria, though heterogeneity and population-specific calibration remain challenges.

Conclusion

Risk-based eligibility models improve LDCT-LCS efficiency by enhancing detection rates and personalization. While PLCOm2012 is prominent, addressing model heterogeneity, ensuring population-specific validation, and calibration are crucial to optimize LDCT-LCS outcomes in Europe. Systematic Review Registration Identifier CRD42025648906.

Schlagwörter

Stichwörter der Autor:innen

cost-effectivenessearly detectioneligibility criterialow-dose computed tomography (LDCT)lung cancer screening

Autor:innen und Institutionen

  • Doctoral Program Public Health, Institute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Roche Austria GmbH, Vienna, Austria.
  • Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
  • Faculty of Medicine, Sigmund Freud Private University, Vienna, Austria.
  • Department of Respiratory and Pulmonary Diseases, Site Penzing of Clinic Ottakring, Vienna Healthcare Group, Vienna, Austria.
  • Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.

Zitieren

APA

Mikl, V. E., Azizzadeh, M., Breyer, M. K., Ten Haaf, K., Ritschl, V., Simon, J., & Stamm, T. (2026). Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review. Public Health Reviews, 47. https://doi.org/10.3389/phrs.2026.1609133

Vancouver

Mikl VE, Azizzadeh M, Breyer MK, Ten Haaf K, Ritschl V, Simon J, et al. Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review. Public Health Reviews. 2026;47. doi:10.3389/phrs.2026.1609133

BibTeX
@article{Mikl2026,
  author = {Mikl, Veronika Elisabeth and Azizzadeh, Mohammad and Breyer, Marie-Kathrin and Ten Haaf, Kevin and Ritschl, Valentin and Simon, Judit and Stamm, Tanja},
  title = {Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review},
  journal = {Public Health Reviews},
  year = {2026},
  volume = {47},
  doi = {10.3389/phrs.2026.1609133}
}
Kostenlos starten →